(Q36691877)

15 August 2017

5 references

23 March 2019

22 June 2019

19 September 2019

18 July 2021

14 January 2024

Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria (English)

1 reference

Plasmodium falciparum malaria

15 August 2017

1 reference

18 July 2021

Plasmodium falciparum

0 references

malaria

0 references

3 references

23 March 2019

22 June 2019

19 September 2019

biomedical investigative technique

1 reference

19 September 2019

2

Nicholas J White

1 reference

15 August 2017

1

Kasia Stepniewska

1 reference

15 August 2017

PMCID

1769507

language of work or name

1 reference

22 December 2006

6 references

15 August 2017

23 March 2019

22 June 2019

19 September 2019

18 July 2021

14 January 2024

6 references

15 August 2017

23 March 2019

22 June 2019

19 September 2019

18 July 2021

14 January 2024

5

1 reference

15 August 2017

127

1 reference

Creative Commons Attribution 2.0 Generic

15 August 2017

5 references

23 March 2019

22 June 2019

19 September 2019

18 July 2021

on focus list of Wikimedia project

14 January 2024

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1475-2875-5-127

0 references

cites work

Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Review and evaluation of methods for computing confidence intervals for the ratio of two proportions and considerations for non-inferiority clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Hazard ratio in clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

A systematic overview of published antimalarial drug trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

What is meant by intention to treat analysis? Survey of published randomised controlled trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Two-sided confidence intervals for the single proportion: comparison of seven methods

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Intention-to-treat analysis: implications for quantitative and qualitative research

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Intention to treat--who should use ITT?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Minimization of sample size when comparing two small probabilities in a non-inferiority safety trial.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769507

International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice

5 September 2018

1 reference

12 December 2020

The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agents

1 reference

12 December 2020

Alternatives for discounting in the analysis of noninferiority trials

1 reference

12 December 2020

Hypotheses and type I error in active-control noninferiority trials

1 reference

12 December 2020

Interval estimation for the difference between independent proportions: comparison of eleven methods

1 reference

12 December 2020

The United States Food and Drug Administration and the end of antibiotics

1 reference

12 December 2020

Identifiers

DOI

10.1186/1475-2875-5-127

1 reference

PMCID

1769507

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

1 reference

PMCID

1769507